Avails Medical

Avails Medical is a private, commercial-stage diagnostics company focused on revolutionizing infectious disease care with its rapid AST platform. The company's core technology is an electronic biosensor that detects pathogen metabolism in real-time, offering a compact, cost-effective alternative to traditional optical methods. With its first FDA-cleared system and an initial commercial agreement, Avails is positioned to address the critical need for faster diagnostics in sepsis management and antimicrobial stewardship. The company is headquartered in Menlo Park, California, and was founded in 2014.

Proprietary electronic biosensor that detects real-time oxidation/reduction changes from pathogen metabolism, enabling rapid, compact, and cost-effective antimicrobial susceptibility testing (AST).

Avails operates in the highly competitive rapid diagnostics and AST market, competing with large multinationals (e.g., bioMérieux, BD, Beckman Coulter) and other innovators using molecular, phenotypic, and mass spectrometry methods. Its key differentiators are the speed and cost-effectiveness of its electrical biosensor platform, and its compact instrument design aimed at easier lab integration.